
Profitability, historical returns, and peer comparisons.
According to Merck KGaA’s latest financial reports and current stock price. The company's current ROE is 8.08%. This represents a change of 299.97% compared to the average of 2.02% of the last 4 quarters.
The mean historical ROE of Merck KGaA over the last ten years is 11.21%. The current 8.08% ROE has changed -27.94% with respect to the historical average. Over the past ten years (40 quarters), MKKGY's ROE was at its highest in in the December 2017 quarter at 7.23%. The ROE was at its lowest in in the March 2019 quarter at 1.07%.
Average
11.21%
Median
11.11%
Minimum
6.57%
Maximum
18.60%
Discovering the peaks and valleys of Merck KGaA ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 59.75%
Maximum Annual ROE = 18.60%
Minimum Annual Increase = -64.68%
Minimum Annual ROE = 6.57%
| Year | ROE | Change |
|---|---|---|
| 2025 | 9.12% | -1.75% |
| 2024 | 9.28% | -12.29% |
| 2023 | 10.58% | -17.46% |
| 2022 | 12.82% | -10.43% |
| 2021 | 14.32% | 22.10% |
| 2020 | 11.73% | 58.69% |
| 2019 | 7.39% | 12.47% |
| 2018 | 6.57% | -64.68% |
| 2017 | 18.60% | 59.75% |
| 2016 | 11.64% | 33.57% |
The current ROE of Merck KGaA (MKKGY) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
9.66%
5-year avg
11.23%
10-year avg
11.21%
Merck KGaA’s ROE is less than Bio-Techne Corporation (8.90%), less than Bio-Rad Laboratories, Inc. (3.15%), less than Danaher Corporation (8.18%), less than Thermo Fisher Scientific Inc. (13.32%), less than Revvity, Inc. (3.50%), less than Agilent Technologies, Inc. (20.47%), less than Waters Corporation (0.81%), greater than Lonza Group AG (-1.28%), less than Element Solutions Inc (7.39%), less than Evonik Industries AG (2.16%),
| Company | ROE | Market cap |
|---|---|---|
| 8.90% | $11.42B | |
| 3.15% | $10.16B | |
| 8.18% | $165.15B | |
| 13.32% | $261.64B | |
| 3.50% | $17.79B | |
| 20.47% | $49.96B | |
| 0.81% | $45.91B | |
| -1.28% | $57.95B | |
| 7.39% | $8.15B | |
| 2.16% | $11.18B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Merck KGaA using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Merck KGaA or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Merck KGaA's ROE?
How is the ROE calculated for Merck KGaA (MKKGY)?
What is the highest ROE for Merck KGaA (MKKGY)?
What is the 3-year average ROE for Merck KGaA (MKKGY)?
What is the 5-year average ROE for Merck KGaA (MKKGY)?
How does the current ROE for Merck KGaA (MKKGY) compare to its historical average?